Focus: 10X Genomics is a public genomics platform company headquartered in Pleasanton, CA, providing sequencing and analysis tools for research and clinical applications across oncology, neurology, and ophthalmology.
Profile data last refreshed 38m ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
14 added, 13 removed. Backfill posture.
3 recent layoff filings (12 mo) — 93 affected
Source: state DOL filings via Big Local News
Attractive for commercial, IT, and operations professionals seeking growth-stage biotech with platform upside; risky for research scientists given thin R&D hiring and ongoing cash burn.
Help build intelligence for 10X Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from 10X Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
8-K Filing: CareDx, Inc. (CDNA) (CIK 0001217234) — EX-99.1
EX-99.1
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Source: state DOL filings, aggregated via Big Local News
No visible regulatory or workforce restructuring warnings; primary risk is cash burn rate if revenue growth stalls.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo